Lonza teams with hospital to produce CAR-T cells at point-of-care
Lonza and Israel-based Sheba Medical collaborate to use the CDMO’s manufacturing platform for point-of-care genetically engineered human CAR-T cell production.
Lonza and Israel-based Sheba Medical collaborate to use the CDMO’s manufacturing platform for point-of-care genetically engineered human CAR-T cell production.
Alternatives to the transactional RFP-bid defense structure “invite greater creativity and innovative options” into sourcing discussions, says Syneos executive.
In response to a growing interest in alternative testing methods, SenzaGen signs a license agreement with MB Research Labs to expand the use of its animal-free testing platform.
Northwell Health taps Clinithink’s CLiX for accelerated patient identification in clinical trials and research.
ACG announces plans to grow its Latin American presence with its newest capsule production plant in Brazil, as it continues to expand its facilities in Asia-Pacific and Europe.
A study carried out by MIT researchers has found that 93% of medications contain excipients with the potential to cause an allergic reaction.
Non-profit organisation, Civica, sees membership reach over 800 hospitals as part of its plan to secure the supply of generic medicine in short supply.